CRVO
CervoMed Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.56
+0.79%Margins
Gross margin
100.0%
EBITDA margin
-9408.8%
EBIT margin
-9661.4%
Net margin
-9408.8%
FCF margin
-8673.4%
-132.2%
Return on equity
-116.8%
Return on assets
-135.7%
Return on invested capital
0.02x
Asset turnover
-$28.0M
Cash from operations
$1.65
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026